Similarly, the treatment of MM cells from 12 MM patients with WEV alone or WEV+NP markedly downregulated the surface expression of CD54 (Figure 2F) but not CXCR4 (Figure 2E), compared to treatment with NP. The gene discussed is CXCR4; the disease is Miyoshi myopathy.